PNC Financial Services Q4 2025 13F Holdings and Activity Report

I. Institutional Overview

The sheer scale of the portfolio—exceeding $183 billion—places PNC in the upper echelon of institutional managers. This level of AUM (Assets Under Management) typically necessitates a diversified approach to manage liquidity and systemic risk. Indeed, the presence of over 5,000 stocks suggests that PNC serves as a massive "clearing house" for a variety of investment strategies, likely ranging from private wealth management and trust services to institutional asset management. The breadth of the holdings ensures that the institution has a footprint in nearly every corner of the investable U.S. equity market, from mega-cap technology giants to micro-cap experimental ventures.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

The philosophy behind this concentration appears to be a bet on the "defensive growth" characteristics of the healthcare sector, specifically the revolution in obesity and diabetes treatments. By allocating over half of its capital to this space, PNC is effectively insulating itself from some of the volatility found in more cyclical sectors like Energy or Materials, while still capturing the high-margin growth of the pharmaceutical industry. However, this concentration also introduces significant regulatory and clinical trial risk, as any systemic change in drug pricing or a major safety recall for a leading drug would have a disproportionate impact on the total portfolio value.

The institution appears to be positioning for a "Soft Landing" or a period of moderate growth where interest rates remain higher for longer. In such an environment, companies with massive balance sheets and "must-have" products (like Eli Lilly’s GLP-1 drugs or Microsoft’s enterprise software) are expected to outperform. The low exposure to Utilities and Real Estate suggests they are not yet ready to bet on a rapid return to a low-interest-rate environment.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

The top 10 holdings of PNC Financial Services represent the "ballast stones" of the portfolio, accounting for a massive portion of the total AUM. This list is a mix of high-conviction individual stocks and broad-market ETFs that provide the necessary liquidity for a $183 billion fund.

The top 10 holdings reveal a "Barbell Strategy." On one end, you have the massive, aggressive growth bet on Eli Lilly. On the other end, you have the ultra-stable, diversified exposure of S&P 500 and Nasdaq-100 ETFs. The middle is filled with "Mega-Cap Quality" stocks. This structure allows PNC to capture explosive upside from a specific industry leader while maintaining enough diversification to survive a broader market downturn.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

A clear trend emerges from the buy list: International Diversification and Factor Tilts. The additions to IDEV (Developed Markets) , DFIV (International Value) , and IEMG (Emerging Markets) indicate that PNC is looking outside the U.S. for valuation opportunities. After a long period of U.S. outperformance, this "Global Rotation" suggests a belief that international markets—particularly value-oriented ones—may offer better risk-adjusted returns in 2026.

The total estimated addition scale across these top targets exceeds $1.2 billion . Much of this capital appears to have been recycled from the "Quality" and "Dividend" factors (see Section V). PNC is effectively rotating out of "Slow and Steady" dividend payers and into "High-Octane" AI growth and "Safe-Haven" Treasuries. This "Barbell" adjustment increases the portfolio's offensiveness (via AIQ) while simultaneously strengthening its defensive walls (via GOVT and AGG).

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

While PNC was aggressive in its additions, it was equally decisive in trimming positions that no longer fit its immediate strategic goals. The sell-side activity this quarter was characterized by a retreat from "Quality Dividend" themes and tactical profit-taking in high-performing tech and energy names.

The common thread among the reductions is a move away from "Value-Trap Defensives." Stocks like Johnson & Johnson (JNJ) and Procter & Gamble (PG) were trimmed. These companies are often seen as "bond proxies." By reducing them and buying actual Treasury bonds (GOVT), PNC is essentially saying: "If I want safety, I'll buy a bond; if I want growth, I'll buy AI. I don't want to be stuck in the middle with slow-growing, expensive consumer staples."

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

PNC’s strategy this quarter is a masterclass in managing a "winner-take-all" portfolio. The institution has allowed Eli Lilly (LLY) to become a dominant, sovereign-like entity within its holdings, effectively turning a diversified bank portfolio into a thematic biotech fund. However, rather than simply sitting on this concentration, PNC is using its other capital to aggressively pivot.

For retail investors, the reference value here is the shift from "Quality" to "Value + Aggressive Growth." PNC is signaling that the "Quality" factor may be overcrowded or overvalued. Instead, they are looking for "Deep Value" internationally and "Hyper Growth" in AI, while using Treasuries for actual protection. This is a sophisticated way to manage a late-cycle market where traditional diversification often fails.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.